Einrichtungen, die zum Universitätsklinikum Erlangen gehören


close-button

Project Types

Third Party Funds Group - Overall project
Third Party Funds Group - Sub project
Third party funded individual grant
Internally funded project
FAU own research funding: EFI / IZKF / EAM ...
Non-FAU Project

Status

Project year

From
To
Emergency barriers in Inflammatory Bowel Diseases - Neutrophil-epithelial crosstalk shapes epithelial restitution in the ulcer microenvironment (SFB/TRR 241) TRR 241: Immun-Epitheliale Signalwege bei chronisch entzündlichen Darmerkrankungen July 1, 2022 - June 30, 2030 EARTHWORM: pEristAlsis in Real-Time Human mri to study the interWOven fRequency & Microstructural properties (DR-EUC-ERC-09_EARTHWORM) Dec. 1, 2024 - Nov. 30, 2029 Synthetic Molecular Communications Across Different Scales: From Theory to Experiments (SyMoCADS) June 1, 2024 - May 31, 2029 Enhancing palliative care in ICU (EPIC) Enhancing palliative care in ICU Jan. 1, 2024 - Dec. 31, 2028 Striking a moving target: From mechanisms of metastatic organ colonisation to novel systemic therapies (SFB/TRR 305 B08) TRR 305: Über die Analyse der metastatischen Koloniebildung zu neuen systemischen Krebstherapien Jan. 1, 2021 - Dec. 31, 2028 FunctIonal optoacousticS for imaging Early onsEt of Gut inflammation (IseeG) Dec. 1, 2023 - Nov. 30, 2028 EMOPROM LCN - Multidisziplinäre Online PROMs im Long-COVID Netzwerk von ambulanten, stationären und rehabilitativen Sektoren in Zusammenarbeit mit Patientinnen und Patienten (SO-BMG_EMOPROM LCN) Nov. 16, 2024 - Nov. 15, 2028 Teilprojekt C5 (GRK 2504 C5) GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention Oct. 1, 2019 - Sept. 30, 2028 GRK 2504: Preclinical evaluation of a combination of checkpoint blockade with dendritic cell vaccination against Merkel Cell Carcinoma and other virally induced cancers (B4) (GRK 2504 B4) GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504) Oct. 1, 2019 - Sept. 30, 2028 GRK 2504: LCMV as model for immune intervention by antigen targeting in chronic viral infections (B2) (GRK 2504 B2) GRK 2504: Neue antivirale Strategien: von der Chemotherapie bis zur Immunintervention (GRK 2504) Jan. 1, 2019 - Sept. 30, 2028